Sponsored Links
| Amylin Sues Lilly For Uncompetitive Activity And Breaching Strategic Alliance Agreements |
 |
 |
 |
| Medical News - Litigation and Medical Malpractice | |||
|
Amylin Pharmaceuticals Inc. is suing Eli Lilly and Company for engaging in uncompetitive behaviour and violating a strategic alliance between the two companies regarding the development and commercialization of diabetes drug exenatide. Amylin says Lilly has teamed up with Boehringer Ingelheim to develop a competing diabetes medication... Read more: Litigation / Medical Malpractice News From Medical News Today
|